March saw dramatic declines in the average UK trade prices for multiple presentations of pramipexole modified-release tablets, according to the latest figures from market researcher WaveData.
Based on trade prices to UK independent pharmacists, the treatment for Parkinson’s disease and restless legs syndrome dominated our table...